Jul 2026· International Journal of Biological Macromolecules· Vol 376, pp.
153574
· 1 citation· 57 references
Medicine
TL;DR
A lactate-p300-AP-1-SPP1 axis that couples ischemic metabolism to microglial chromatin remodeling and post-stroke neuroinflammatory injury is defined.
Abstract
Cerebral ischemia causes profound metabolic disruption, but how ischemia-associated metabolites reshape microglial chromatin and inflammatory function remains unclear. Here we identify histone lactylation as an epigenetic mechanism linking ischemic metabolic stress to pathogenic microglial activation. In transient middle cerebral artery occlusion mice and oxygen-glucose deprivation/reperfusion models, ischemic stress robustly increased H3K18la and H4K12la in microglia. CUT&Tag profiling showed widespread remodeling of both lactylation landscapes, with gained peaks preferentially associated with inflammatory, chemotactic, migratory and efferocytic programs. Integration with microglial RNA sequencing identified a concordantly activated gene network enriched for TNF, NF-κB, IL-17 and cytoskeletal regulatory pathways, with Spp1 emerging as a prominent effector linked to ischemia-induced lactylation. Motif enrichment and locus-level analyses implicated AP-1-associated regulatory elements, and ChIP-qPCR confirmed increased H3K18la and H4K12la at Fos and Spp1 regulatory regions after ischemia-like stress. Mechanistically, p300 depletion or inhibition reduced H3K18la/H4K12la accumulation, impaired AP-1-associated promoter engagement, and suppressed Fos, Spp1 and chemokine induction. Non-lactylatable H3K18R and H4K12R mutants attenuated Fos-Spp1 transcription and microglial migration, supporting cooperative regulation by these two marks. Functionally, microglia-specific Spp1 deletion reduced inflammatory microglial activation, neuronal apoptosis and long-term neurological deficits after ischemic injury. Pharmacological inhibition of p300 or AP-1, and SPP1 neutralization, similarly limited neuroinflammation and improved sensorimotor and cognitive recovery. Together, our findings define a lactate-p300-AP-1-SPP1 axis that couples ischemic metabolism to microglial chromatin remodeling and post-stroke neuroinflammatory injury.
HNRNPK lactylation acts as a metabolic sensor coupling lactate accumulation to pathogenic Jag2 splicing and offers a precise therapeutic strategy to limit inflammation and preserve cardiac function in ischemic heart disease.
Su-Yun Chen, Si-Man Shen, Wen-Mei Su et al.· Circulation· 0 citations
Findings support the involvement of C5aR1-sensitive inflammatory signaling and JMJD3/H3K27me3-related epigenetic regulation in PA-associated microglial inflammatory responses.
Liqing Chen, Sanqing Xu, Yan Liu et al.· Journal of Neuroimmune Pharm...· 0 citations
A novel autophagy–NBR1/TRIM33/TRIM33–ACSL3 regulatory axis that drives ferroptosis in CIRI is revealed, highlighting a promising therapeutic strategy for ischemic stroke through cotargeting autophagy and ferroptosis.
Yue-Qing Yang, Ming Zhao, Yi-Bo Feng et al.· Antioxidants and Redox Signa...· 0 citations
LILRB4 attenuates ischemic brain injury by suppressing STING/RIPK3‐mediated microglial necroptosis and neuroinflammation, emphasizing its significance as a potential neuroprotective therapy.
Jing-Long Hu, Mei-Juan Zhang, Pin-Yi Liu et al.· Glia· 0 citations
Microglia-targeted RIOK3 knockdown reduced infarct volume, improved early neurological and sensorimotor outcomes, preserved microglial process complexity, and reduced post-ischemic inflammation, and highlight the RIOK-YBX1 axis as a potential therapeutic target for ischemic stroke.
Yang Geng, Ningning Zong, Chao Zhou et al.· Experimental Neurology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.